ATE549416T1 - Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten - Google Patents

Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten

Info

Publication number
ATE549416T1
ATE549416T1 AT06789292T AT06789292T ATE549416T1 AT E549416 T1 ATE549416 T1 AT E549416T1 AT 06789292 T AT06789292 T AT 06789292T AT 06789292 T AT06789292 T AT 06789292T AT E549416 T1 ATE549416 T1 AT E549416T1
Authority
AT
Austria
Prior art keywords
compositions
methods
autoimmune diseases
detecting autoimmune
detecting
Prior art date
Application number
AT06789292T
Other languages
English (en)
Inventor
Alexander Abbas
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE549416T1 publication Critical patent/ATE549416T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Biochemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06789292T 2005-08-05 2006-08-02 Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten ATE549416T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70620505P 2005-08-05 2005-08-05
PCT/US2006/030241 WO2007019219A2 (en) 2005-08-05 2006-08-02 Methods and compositions for detecting autoimmune disorders

Publications (1)

Publication Number Publication Date
ATE549416T1 true ATE549416T1 (de) 2012-03-15

Family

ID=37663302

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06789292T ATE549416T1 (de) 2005-08-05 2006-08-02 Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten

Country Status (11)

Country Link
US (3) US20070092890A1 (de)
EP (2) EP1945800B1 (de)
AT (1) ATE549416T1 (de)
AU (1) AU2006278561C1 (de)
CA (1) CA2614455A1 (de)
DK (1) DK2327792T3 (de)
ES (2) ES2383966T3 (de)
PL (1) PL2327792T3 (de)
PT (1) PT2327792E (de)
SI (1) SI2327792T1 (de)
WO (1) WO2007019219A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101473045B (zh) 2006-04-24 2016-08-03 健泰科生物技术公司 用于检测自身免疫性病症的方法和组合物
EP2712930A3 (de) * 2006-12-06 2014-04-23 MedImmune, LLC Interferon-alpha-induzierte pharmakodynamische Marker
AU2008247398B2 (en) * 2007-05-03 2013-10-10 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
US20100261172A1 (en) * 2007-05-03 2010-10-14 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
EP3318643A3 (de) 2007-05-21 2018-06-20 Genentech, Inc. Verfahren und zusammensetzungen zur identifizierung und behandlung von lupus
PL2219452T3 (pl) * 2007-11-05 2016-04-29 Medimmune Llc Sposoby leczenia twardziny
CA2714410A1 (en) 2008-02-08 2009-08-13 Medimmune, Llc Disease markers and uses thereof
US20120251546A1 (en) * 2009-09-03 2012-10-04 Medimmune Llc Type 1 inteferon diagnostic
IN2012DN02374A (de) * 2009-09-18 2015-08-21 Univ Rutgers
CN106929568A (zh) 2009-10-07 2017-07-07 弗·哈夫曼-拉罗切有限公司 用于治疗、诊断和监控狼疮的方法
US8824769B2 (en) * 2009-10-16 2014-09-02 General Electric Company Process and system for analyzing the expression of biomarkers in a cell
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
ES2372762B1 (es) * 2010-07-02 2012-11-28 Consejo Superior De Investigaciones Científicas (Csic) Método y kit para la detección de la activación de interferón y la respuesta inflamatoria independiente de interferón.
WO2012024236A1 (en) * 2010-08-14 2012-02-23 Biogen Idec Ma Inc. LTβR BLOCKADE: METHODS FOR OPTIMIZING THERAPEUTIC RESPONSIVENESS OF PATIENTS
WO2016179268A1 (en) * 2015-05-05 2016-11-10 University Of Florida Research Foundation, Inc. Diagnostic microarray, system and method

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4657760A (en) 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5206344A (en) 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5225212A (en) 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US6214790B1 (en) * 1998-04-10 2001-04-10 Mayo Foundation For Medical Education And Research Neo-tryptophan
JP2003529774A (ja) 2000-03-31 2003-10-07 ジェネンテック・インコーポレーテッド 遺伝子発現を検出し定量するための構成物及び方法
US20030148298A1 (en) * 2001-04-03 2003-08-07 O''toole Margot Methods for diagnosing and treating systemic lupus erythematosus disease and compositions thereof
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
EP1511690A4 (de) * 2002-05-16 2007-10-24 Univ Vanderbilt Verfahren zur vorhersage von autoimmunerkrankungen
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
WO2004047728A2 (en) * 2002-11-26 2004-06-10 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2004076639A2 (en) * 2003-02-26 2004-09-10 Wyeth Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
WO2005123113A2 (en) * 2004-06-14 2005-12-29 Intermune, Inc. Interferon compositions and methods of use thereof
EP1789798A4 (de) * 2004-08-13 2009-02-18 Xceed Molecular Corp Marker für den nachweis von autoimmunkrankheiten
US7571055B2 (en) * 2004-10-13 2009-08-04 Regents Of The University Of Minnesota Systemic lupus erythematosus

Also Published As

Publication number Publication date
US20100279298A1 (en) 2010-11-04
AU2006278561A1 (en) 2007-02-15
US20080318800A1 (en) 2008-12-25
AU2006278561C1 (en) 2013-05-02
EP2327792B1 (de) 2013-10-02
EP1945800B1 (de) 2012-03-14
HK1158700A1 (en) 2012-07-20
ES2432026T3 (es) 2013-11-29
DK2327792T3 (da) 2014-01-13
WO2007019219A2 (en) 2007-02-15
EP2327792A1 (de) 2011-06-01
PL2327792T3 (pl) 2014-03-31
EP2327792B9 (de) 2013-12-18
US20070092890A1 (en) 2007-04-26
CA2614455A1 (en) 2007-02-15
ES2383966T3 (es) 2012-06-27
EP1945800A2 (de) 2008-07-23
WO2007019219A3 (en) 2007-05-31
SI2327792T1 (sl) 2013-12-31
AU2006278561B2 (en) 2012-11-01
PT2327792E (pt) 2013-11-21

Similar Documents

Publication Publication Date Title
UA95768C2 (ru) Антагонисты мускариновых рецепторов ацетилхолина
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
DE602005020209D1 (de) System zur Evaluierung von Herzstörungen
DE602004007901D1 (de) Vorrichtung zur Verringerung des Aufpralls von Fussgängern
DE602006002766D1 (de) Gestängeelevator und Verfahren
DE112006002764A5 (de) Vorrichtung zum Einbau von Küchen
ATE540034T1 (de) Ä4-(6-halo-7-substituierte-2,4-dioxo-1,4-dihydr - 2h-chinazolin-3-yl)-phenylü-5-chloro-thiophen-2 yl-sulfonylharnstoffe und relevante formen und verfahren
DE602006007402D1 (de) Vorrichtung zur Radzustandsbestimmung
EP1875237A4 (de) Docetaxel-immuntest
DE602006005437D1 (de) Verfahren und Vorrichtung zum Herstellung von Bauteilen
DE602006006759D1 (de) Vorrichtung zum Nachweis von Reaktionen
DE502005000967D1 (de) Vorrichtung zum Fixieren von beweglich gelagerten Teilen
NL1030418A1 (nl) Azabenzoxazolen voor de behandeling van CZS-stoornissen.
DE602006011633D1 (de) Vorrichtung zur werkzeugausspannung
EP1902068A4 (de) Egfr-inhibitoren als promotoren der neuritregeneration
DE602006020371D1 (de) Antriebsapparat
DE602005002311D1 (de) Vorrichtung zur Wiederherstellung des Sehens
FR2890857B1 (fr) Composition a base de concentres mineraux derives de pierres precieuses.
EP1907920A4 (de) Verfahren und einrichtung zum eingeben von text
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
EP1778878A4 (de) Verfahren und zusammensetzungen zum nachweis von rhinoviren
DE602006004469D1 (de) Vorrichtung zur werkzeugausspannung
DE602006004272D1 (de) Verfahren zur Befestigung von Polierkissen und Vorrichtung zum Befestigen derselben
DE112006000410B8 (de) Pfropf-Copolymer und Verfahren zum Herstellen desselben
IL185653A (en) Antibodies that call for the 1-kim salt region